Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Thomas Lönngren"'
Autor:
Zoltán Kaló, Thomas Lönngren, Nancy Devlin, Kevin Marsh, Filip Mussen, John B. Watkins, Meindert Boysen, Rob Baltussen, Praveen Thokala, Stuart Peacock, Maarten Joost IJzerman
Publikováno v:
Value in health, 19(2), 125-137. Elsevier
Health care decisions are complex and involve confronting trade-offs between multiple, often conflicting objectives. Using structured, explicit approaches to decisions involving multiple criteria can improve the quality of decision making. A set of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbc8e52dc408bdd89fb23970866bc69e
Autor:
Nikolaos Zafiropoulous, Veronika Jekerle, Falk Ehmann, Piotr Kramarz, Hans-Georg Eichler, Thomas Lönngren, Barbara Fasolo, Angus Nicoll, Lawrence D. Phillips
Publikováno v:
European journal of public health. 23(4)
Background: Shortly after the H1N1 influenza virus reached pandemic status in June 2009, the benefit–risk project team at the European Medicines Agency recognized this presented a research opportunity for testing the usefulness of a decision analys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5e48402e0e46f50b8ba77476ba0be30
https://pubmed.ncbi.nlm.nih.gov/23402804
https://pubmed.ncbi.nlm.nih.gov/23402804
Autor:
Thomas, Lönngren
Publikováno v:
Nature reviews. Drug discovery. 5(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7b64e183c2f4038d7cf9863c287dffdc
https://pubmed.ncbi.nlm.nih.gov/16557656
https://pubmed.ncbi.nlm.nih.gov/16557656
Autor:
Thomas Lönngren
Publikováno v:
Nature Reviews Drug Discovery. 5:182-182
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3007942f8d8ec058b59a51a6bf743096
https://doi.org/10.1038/nrd1991
https://doi.org/10.1038/nrd1991
Autor:
Emmanuelle Voisin, Sarah Garner, Thomas Lönngren, Moncef Slaoui, Yann Le Cam, Marc Dunoyer, David Uguen, Carlo Incerti
Publikováno v:
Orphanet Journal of Rare Diseases
There is growing recognition that the current research-and-development (R&D) and innovation-regulation ecosystem could be made more efficient to stimulate and support access to innovative therapies for those patients with rare, life-threatening disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2057c00e631e4452cbf6dcbe18b54ba6